Yellow Fever Vaccine Market By Type of Vaccine (Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine), By Application (Prevention of Yellow Fever, Travel Vaccination, Outbreak Control, Prevention of Yellow Fever in Special Populations), By Distribution Channel (Direct Sales, Government Procurement, Online Pharmacies, Retail Pharmacies, Wholesale Distribution), By End User (Hospitals, Clinics, Public Health Organizations, Travel Health Centers, Pharmacies, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Yellow Fever Vaccine Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Increasing awareness about yellow fever prevention globally

3.2.2. Rising international travel and tourism boosting vaccination demand

3.2.3. Improved healthcare infrastructure in developing countries facilitating vaccine access

3.3. Key industry pitfalls & challenges

3.3.1. Public hesitation and misconceptions about vaccine safety

3.3.2. Limited availability and supply chain challenges in remote areas

3.3.3. Geopolitical instability affecting vaccination programs in certain regions

3.4. Market Opportunities

3.4.1. Expanding vaccination campaigns in emerging markets

3.4.2. Rising demand for travel-related vaccinations and health certifications

3.4.3. Growing collaboration between governments and global health organizations

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Yellow Fever Vaccine Market, Type of Vaccine Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Type of Vaccine, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Live Attenuated Vaccine

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Inactivated Vaccine

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Recombinant Vaccine

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Yellow Fever Vaccine Market, Application Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Application, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Prevention of Yellow Fever

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Travel Vaccination

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Outbreak Control

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Others

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Yellow Fever Vaccine Market, Distribution Channel Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Distribution Channel, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Direct Sales

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Government Procurement

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Online Pharmacies

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. Retail Pharmacies

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.6. Wholesale Distribution

6.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Yellow Fever Vaccine Market, End-user Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By End-user, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Hospitals

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Clinics

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Public Health Organizations

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.5. Travel Health Centers

7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.6. Pharmacies

7.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.7. Others

7.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Yellow Fever Vaccine Market, Region Segment Analysis

8.1. Overview

8.1.1. Global Market Revenue Share, By Region, 2025 & 2035

8.1.2. Global Market Revenue, By Region, 2025-2035(USD Billion)

8.2. North America

8.2.1. North America Market Revenue, By Country, 2025-2035(USD Billion)

8.2.2. North America Market Revenue, By Type of Vaccine, 2025-2035

8.2.3. North America Market Revenue, By Application, 2025-2035

8.2.4. North America Market Revenue, By Distribution Channel, 2025-2035

8.2.5. North America Market Revenue, By End-user, 2025-2035

8.2.6. The U.S.

8.2.6.1. U.S. Market Revenue, By Type of Vaccine, 2025-2035

8.2.6.2. U.S. Market Revenue, By Application, 2025-2035

8.2.6.3. U.S. Market Revenue, By Distribution Channel, 2025-2035

8.2.6.4. U.S. Market Revenue, By End-user, 2025-2035

8.2.7. Canada

8.2.7.1. Canada Market Revenue, By Type of Vaccine, 2025-2035

8.2.7.2. Canada Market Revenue, By Application, 2025-2035

8.2.7.3. Canada Market Revenue, By Distribution Channel, 2025-2035

8.2.7.4. Canada Market Revenue, By End-user, 2025-2035

8.3. Europe

8.3.1. Europe Market Revenue, By Country, 2025-2035(USD Billion)

8.3.2. Europe Market Revenue, By Type of Vaccine, 2025-2035

8.3.3. Europe Market Revenue, By Application, 2025-2035

8.3.4. Europe Market Revenue, By Distribution Channel, 2025-2035

8.3.5. Europe Market Revenue, By End-user, 2025-2035

8.3.6. Germany

8.3.6.1. Germany Market Revenue, By Type of Vaccine, 2025-2035

8.3.6.2. Germany Market Revenue, By Application, 2025-2035

8.3.6.3. Germany Market Revenue, By Distribution Channel, 2025-2035

8.3.6.4. Germany Market Revenue, By End-user, 2025-2035

8.3.7. France

8.3.7.1. France Market Revenue, By Type of Vaccine, 2025-2035

8.3.7.2. France Market Revenue, By Application, 2025-2035

8.3.7.3. France Market Revenue, By Distribution Channel, 2025-2035

8.3.7.4. France Market Revenue, By End-user, 2025-2035

8.3.8. U.K.

8.3.8.1. U.K. Market Revenue, By Type of Vaccine, 2025-2035

8.3.8.2. U.K. Market Revenue, By Application, 2025-2035

8.3.8.3. U.K. Market Revenue, By Distribution Channel, 2025-2035

8.3.8.4. U.K. Market Revenue, By End-user, 2025-2035

8.3.9. Italy

8.3.9.1. Italy Market Revenue, By Type of Vaccine, 2025-2035

8.3.9.2. Italy Market Revenue, By Application, 2025-2035

8.3.9.3. Italy Market Revenue, By Distribution Channel, 2025-2035

8.3.9.4. Italy Market Revenue, By End-user, 2025-2035

8.3.10. Spain

8.3.10.1. Spain Market Revenue, By Type of Vaccine, 2025-2035

8.3.10.2. Spain Market Revenue, By Application, 2025-2035

8.3.10.3. Spain Market Revenue, By Distribution Channel, 2025-2035

8.3.10.4. Spain Market Revenue, By End-user, 2025-2035

8.3.11. Rest of Europe

8.3.11.1. Rest of Europe Market Revenue, By Type of Vaccine, 2025-2035

8.3.11.2. Rest of Europe Market Revenue, By Application, 2025-2035

8.3.11.3. Rest of Europe Market Revenue, By Distribution Channel, 2025-2035

8.3.11.4. Rest of Europe Market Revenue, By End-user, 2025-2035

8.4. Asia Pacific

8.4.1. Asia Pacific Market Revenue, By Country, 2025-2035(USD Billion)

8.4.2. Asia Pacific Market Revenue, By Type of Vaccine, 2025-2035

8.4.3. Asia Pacific Market Revenue, By Application, 2025-2035

8.4.4. Asia Pacific Market Revenue, By Distribution Channel, 2025-2035

8.4.5. Asia Pacific Market Revenue, By End-user, 2025-2035

8.4.6. China

8.4.6.1. China Market Revenue, By Type of Vaccine, 2025-2035

8.4.6.2. China Market Revenue, By Application, 2025-2035

8.4.6.3. China Market Revenue, By Distribution Channel, 2025-2035

8.4.6.4. China Market Revenue, By End-user, 2025-2035

8.4.7. Japan

8.4.7.1. Japan Market Revenue, By Type of Vaccine, 2025-2035

8.4.7.2. Japan Market Revenue, By Application, 2025-2035

8.4.7.3. Japan Market Revenue, By Distribution Channel, 2025-2035

8.4.7.4. Japan Market Revenue, By End-user, 2025-2035

8.4.8. India

8.4.8.1. India Market Revenue, By Type of Vaccine, 2025-2035

8.4.8.2. India Market Revenue, By Application, 2025-2035

8.4.8.3. India Market Revenue, By Distribution Channel, 2025-2035

8.4.8.4. India Market Revenue, By End-user, 2025-2035

8.4.9. Australia

8.4.9.1. Australia Market Revenue, By Type of Vaccine, 2025-2035

8.4.9.2. Australia Market Revenue, By Application, 2025-2035

8.4.9.3. Australia Market Revenue, By Distribution Channel, 2025-2035

8.4.9.4. Australia Market Revenue, By End-user, 2025-2035

8.4.10. South Korea

8.4.10.1. South Korea Market Revenue, By Type of Vaccine, 2025-2035

8.4.10.2. South Korea Market Revenue, By Application, 2025-2035

8.4.10.3. South Korea Market Revenue, By Distribution Channel, 2025-2035

8.4.10.4. South Korea Market Revenue, By End-user, 2025-2035

8.4.11. Singapore

8.4.11.1. Singapore Market Revenue, By Type of Vaccine, 2025-2035

8.4.11.2. Singapore Market Revenue, By Application, 2025-2035

8.4.11.3. Singapore Market Revenue, By Distribution Channel, 2025-2035

8.4.11.4. Singapore Market Revenue, By End-user, 2025-2035

8.4.12. Rest of Asia Pacific

8.4.12.1. Rest of Asia Pacific Market Revenue, By Type of Vaccine, 2025-2035

8.4.12.2. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

8.4.12.3. Rest of Asia Pacific Market Revenue, By Distribution Channel, 2025-2035

8.4.12.4. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

8.5. Latin America

8.5.1. Latin America Market Revenue, By Country, 2025-2035(USD Billion)

8.5.2. Latin America Market Revenue, By Type of Vaccine, 2025-2035

8.5.3. Latin America Market Revenue, By Application, 2025-2035

8.5.4. Latin America Market Revenue, By Distribution Channel, 2025-2035

8.5.5. Latin America Market Revenue, By End-user, 2025-2035

8.5.6. Brazil

8.5.6.1. Brazil Market Revenue, By Type of Vaccine, 2025-2035

8.5.6.2. Brazil Market Revenue, By Application, 2025-2035

8.5.6.3. Brazil Market Revenue, By Distribution Channel, 2025-2035

8.5.6.4. Brazil Market Revenue, By End-user, 2025-2035

8.5.7. Argentina

8.5.7.1. Argentina Market Revenue, By Type of Vaccine, 2025-2035

8.5.7.2. Argentina Market Revenue, By Application, 2025-2035

8.5.7.3. Argentina Market Revenue, By Distribution Channel, 2025-2035

8.5.7.4. Argentina Market Revenue, By End-user, 2025-2035

8.5.8. Mexico

8.5.8.1. Mexico Market Revenue, By Type of Vaccine, 2025-2035

8.5.8.2. Mexico Market Revenue, By Application, 2025-2035

8.5.8.3. Mexico Market Revenue, By Distribution Channel, 2025-2035

8.5.8.4. Mexico Market Revenue, By End-user, 2025-2035

8.5.9. Rest of Latin America

8.5.9.1. Rest of Latin America Market Revenue, By Type of Vaccine, 2025-2035

8.5.9.2. Rest of Latin America Market Revenue, By Application, 2025-2035

8.5.9.3. Rest of Latin America Market Revenue, By Distribution Channel, 2025-2035

8.5.9.4. Rest of Latin America Market Revenue, By End-user, 2025-2035

8.6. MEA

8.6.1. MEA Market Revenue, By Country, 2025-2035(USD Billion)

8.6.2. MEA Market Revenue, By Type of Vaccine, 2025-2035

8.6.3. MEA Market Revenue, By Application, 2025-2035

8.6.4. MEA Market Revenue, By Distribution Channel, 2025-2035

8.6.5. MEA Market Revenue, By End-user, 2025-2035

8.6.6. GCC Countries

8.6.6.1. GCC Countries Market Revenue, By Type of Vaccine, 2025-2035

8.6.6.2. GCC Countries Market Revenue, By Application, 2025-2035

8.6.6.3. GCC Countries Market Revenue, By Distribution Channel, 2025-2035

8.6.6.4. GCC Countries Market Revenue, By End-user, 2025-2035

8.6.7. South Africa

8.6.7.1. South Africa Market Revenue, By Type of Vaccine, 2025-2035

8.6.7.2. South Africa Market Revenue, By Application, 2025-2035

8.6.7.3. South Africa Market Revenue, By Distribution Channel, 2025-2035

8.6.7.4. South Africa Market Revenue, By End-user, 2025-2035

8.6.8. Rest of Middle-East & Africa

8.6.8.1. Rest of Middle-East & Africa Market Revenue, By Type of Vaccine, 2025-2035

8.6.8.2. Rest of Middle-East & Africa Market Revenue, By Application, 2025-2035

8.6.8.3. Rest of Middle-East & Africa Market Revenue, By Distribution Channel, 2025-2035

8.6.8.4. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

9. Company Profile

9.1. Sanofi Pasteur

9.1.1. Business Overview

9.1.2. Financial Performance

9.1.3. Product/Service Offerings

9.1.4. Strategies & recent developments

9.1.5. SWOT Analysis

9.2. Bio-Manguinhos

9.2.1. Business Overview

9.2.2. Financial Performance

9.2.3. Product/Service Offerings

9.2.4. Strategies & recent developments

9.2.5. SWOT Analysis

9.3. FSUE Chumakov

9.3.1. Business Overview

9.3.2. Financial Performance

9.3.3. Product/Service Offerings

9.3.4. Strategies & recent developments

9.3.5. SWOT Analysis

9.4. Institut Pasteur de Dakar

9.4.1. Business Overview

9.4.2. Financial Performance

9.4.3. Product/Service Offerings

9.4.4. Strategies & recent developments

9.4.5. SWOT Analysis

9.5. iBio, Inc.

9.5.1. Business Overview

9.5.2. Financial Performance

9.5.3. Product/Service Offerings

9.5.4. Strategies & recent developments

9.5.5. SWOT Analysis

9.6. GlaxoSmithKline PLC

9.6.1. Business Overview

9.6.2. Financial Performance

9.6.3. Product/Service Offerings

9.6.4. Strategies & recent developments

9.6.5. SWOT Analysis

9.7. Merck & Co., Inc.

9.7.1. Business Overview

9.7.2. Financial Performance

9.7.3. Product/Service Offerings

9.7.4. Strategies & recent developments

9.7.5. SWOT Analysis

9.8. Biological E Limited

9.8.1. Business Overview

9.8.2. Financial Performance

9.8.3. Product/Service Offerings

9.8.4. Strategies & recent developments

9.8.5. SWOT Analysis

9.9. Panacea Biotec

9.9.1. Business Overview

9.9.2. Financial Performance

9.9.3. Product/Service Offerings

9.9.4. Strategies & recent developments

9.9.5. SWOT Analysis

9.10. Takeda Pharmaceutical Company Ltd

9.10.1. Business Overview

9.10.2. Financial Performance

9.10.3. Product/Service Offerings

9.10.4. Strategies & recent developments

9.10.5. SWOT Analysis

9.11. Valneva SE

9.11.1. Business Overview

9.11.2. Financial Performance

9.11.3. Product/Service Offerings

9.11.4. Strategies & recent developments

9.11.5. SWOT Analysis

9.12. Bavarian Nordic

9.12.1. Business Overview

9.12.2. Financial Performance

9.12.3. Product/Service Offerings

9.12.4. Strategies & recent developments

9.12.5. SWOT Analysis

9.13. Hualan Biological Engineering Inc.

9.13.1. Business Overview

9.13.2. Financial Performance

9.13.3. Product/Service Offerings

9.13.4. Strategies & recent developments

9.13.5. SWOT Analysis

9.14. Wockhardt Ltd.

9.14.1. Business Overview

9.14.2. Financial Performance

9.14.3. Product/Service Offerings

9.14.4. Strategies & recent developments

9.14.5. SWOT Analysis

9.15. AbbVie Inc.

9.15.1. Business Overview

9.15.2. Financial Performance

9.15.3. Product/Service Offerings

9.15.4. Strategies & recent developments

9.15.5. SWOT Analysis

9.16. Serum Institute of India Pvt. Ltd.

9.16.1. Business Overview

9.16.2. Financial Performance

9.16.3. Product/Service Offerings

9.16.4. Strategies & recent developments

9.16.5. SWOT Analysis

9.17. CureVac AG

9.17.1. Business Overview

9.17.2. Financial Performance

9.17.3. Product/Service Offerings

9.17.4. Strategies & recent developments

9.17.5. SWOT Analysis